SCHEMBL19981658

SCHEMBL19981658

Cc1cc(-c2cc(Nc3cnccn3)c(=O)[nH]n2)ccc1F

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GSK3B P49841 4/20 0.41
GSK3A P49840 3/20 0.41
DYRK1A Q13627 3/20 0.41
NPC1 O15118 3/20 0.40
RAB9A P51151 3/20 0.40
MEN1 O00255 2/20 0.40
CASP3 P42574 2/20 0.40
KMT2A Q03164 2/20 0.40
SENP8 Q96LD8 2/20 0.40
SENP7 Q9BQF6 2/20 0.40
SENP6 Q9GZR1 2/20 0.40
BTK Q06187 4/20 0.40
GRIN1 Q05586 6/20 0.38
GRIN2B Q13224 6/20 0.38
CHEK1 O14757 1/20 0.36
MKNK1 Q9BUB5 1/20 0.36
ALK Q9UM73 2/20 0.35
DAPK3 O43293 2/20 0.35
NTRK1 P04629 2/20 0.35
PIM1 P11309 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13363463 0.80 GSK3A (0.43) GSK3BGSK3ADYRK1ANPC1RAB9A
SCHEMBL9984648 0.73 BTK (0.49) NPC1RAB9AMEN1KMT2ABTK
SCHEMBL12045170 0.72 GSK3A (0.41) GSK3BGSK3ADYRK1ABTKMKNK1
SCHEMBL2409087 0.71 PIM1 (0.46) GSK3BGSK3ADYRK1ANPC1RAB9A
SCHEMBL1925367 0.68 ALPL (0.51) GSK3BRETKDR
SCHEMBL1924983 0.68 ALPL (0.47) GSK3BNPC1RAB9ACASP3SENP8
SCHEMBL8415608 0.67 NPC1 (0.56) GSK3BGSK3ADYRK1ANPC1RAB9A
SCHEMBL12595734 0.66 LMNA (0.60) GSK3BGSK3ADYRK1AMEN1KMT2A
SCHEMBL19981738 0.66 BTK (0.37) GSK3BGSK3ADYRK1ARAB9AMEN1
SCHEMBL14985532 0.63 MAPT (0.46) GSK3BGSK3ADYRK1ABTKALK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2365970-B1 PYRIDAZINONES AND THEIR USE AS BTK INHIBITORS GILEAD CONNECTICUT INC (US) 2018-03-21 EP disclosed